News Updates from the 83rd Scientific Sessions
A panel of experts will take a closer look at changes to the American Diabetes Association® Standards of Care in Diabetes. Eric L. Johnson, MD, said that while many cornerstones of diabetes care remain in place, several topics warrant new emphasis, including sleep health, social determinants of health, hypertension, and medications.
Read more
Two experts will present research on eliminating senescent cells that impact diabetes and aging-related metabolic disease. James L. Kirkland, MD, PhD, will discuss the use of senolytic drugs, and Anil Bhushan, PhD, will share his immunotherapy approach to eliminate senescent cells. Read more
A panel of diabetes and cardiovascular experts, including Jan Borén, MD, PhD, will discuss cardiovascular disease and people with diabetes. The symposium will cover contributing factors to cardiovascular residual risk, new drug targets, and methods to assess disease. Read more
As part of a panel in the ADA Diabetes Journal Symposium, Jonathan Z. Long, PhD, will discuss signaling pathways in energy metabolism, including exercise-induced mediators of body adiposity. He will also share cutting-edge research using a cell-type-specific proteomic approach. Read more
In recent years, telehealth technology has been more readily available and effective in connecting providers and patients. Jennifer Raymond, MD, MCR, will make the case for using telehealth in psychological care, while Michael A. Harris, PhD, will make the case for more research into telehealth models before wide adoption for this kind of care. Read more
Sarah C. Westen will explain what the Psychosocial Subcommittee of the Youth Strategies Committee has accomplished over the past two years. She will share videos created by the team as well as strategies to help improve communication between health care teams and children and their families. Read more
"Sip & Chat" with Alice Cheng, MD, FRCPC, and Michael Natter, MD, on Sunday in the Exhibit Hall. Dr. Cheng, co-host of the Diabetes Care “On Air” podcast and Scientific Sessions Meeting Planning Committee Chair, will interview Dr. Natter, a visual artist and endocrinologist, on how his artistic eye influenced his medical practice. Read more
As the 83rd Scientific Sessions got underway at the San Diego Convention Center, attendees gathered in the Exhibit Hall on Friday evening for a Networking Reception with exhibitors. In addition to providing an opportunity to engage with industry leaders, the event offered a preview of the Poster Hall and a venue to connect with friends and colleagues from across the country and around the world. Read more
In a new Scientific Sessions event that begins Saturday at 4:30 p.m. PT in Halls GH, six diabetes innovators will have the opportunity to pitch their ideas to a panel of potential funders and a live audience. ADA Chief Scientific and Medical Officer Robert Gabbay, MD, PhD, will be one of the moderators. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
Read More
In a symposium that begins Saturday at 4:30 p.m. PT in Ballroom 6A-B, experts including Inês Barroso, PhD, will present information on how GWAS and PRS have helped in the prevention, early diagnosis, and management of type 2 diabetes. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
Read MoreMatthias H. Tschöp, MD, discusses the research that led him to be named the recipient of the ADA's 2023 Banting Medal for Scientific Achievement. He will deliver an award lecture on Sunday at 10:30 a.m. PT in Halls GH. Watch a livestream or catch the recording on-demand on the virtual platform at ADA2023.org.
Alka M. Kanaya, MD, is the recipient of the 2023 Kelly West Award for Outstanding Achievement in Epidemiology. The award recognizes significant contributions to the field of diabetes epidemiology. Dr. Kanaya will present the Kelly West Award for Outstanding Achievement in Epidemiology Lecture on Saturday at 3:15 p.m. PT in Ballroom 6A-B. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
In a panel discussion that begins Saturday at 3:15 p.m. PT in Ballroom 20A-C, Ellen Leschek, MD, and others will discuss teplizumab clinical trial results and the role of the CD3-directed monoclonal antibody in delaying the progression from stage 2 type 1 diabetes to stage 3. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
Read More
Presenter Zhila Semnani-Azad, PhD, shares insight into a symposium that begins Saturday at 4:30 p.m. PT in Ballroom 20A-C. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
Read More
This Ask the Expert session includes presentations on continuous glucose monitoring in chronic kidney disease, leveraging accessibility features for individuals with low vision or hearing loss, solutions for individuals with loss of dexterity, and optimizing technology for individuals with intellectual disability. The session begins Saturday at 1:30 p.m. PT in Ballroom 20A-C. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
Tze-Woei Tan, MBBS, MPH, FACS, is the recipient of the 2023 Roger Pecoraro Award. The award honors outstanding scientific achievement in the prevention, treatment, and management of diabetic foot complications. Dr. Tan will deliver the Roger Pecoraro Award Lecture on Saturday at 1:30 p.m. PT in Room 28. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
Save big on official American Diabetes Association® apparel, gifts, and professional books at the Shop Diabetes Store in the Sails Pavilion in the upper level of the convention center. Every purchase supports diabetes research, advocacy, and educational programs. Hours of operation are from 7:30 a.m. to 6:30 p.m. PT on Saturday and Sunday, and 7:30 a.m. to 4:30 p.m. PT on Monday.
Presenter Sue-Ellen Anderson-Haynes, MS, RDN, CDCES, LDN, CPT, shares insight into a panel discussion that begins Saturday at 11:30 a.m. PT in Room 30. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
Read More
Stop by the Exhibit Hall on the ground level of the convention center to see the latest products and services in diabetes care, as well as featured industry events. The hall is open from 10:00 a.m. to 4:00 p.m. PT on Saturday and Sunday, and 10:00 a.m. to 2:00 p.m. PT on Monday.
Alka M. Kanaya, MD, discusses the research that led her to be named the recipient of the ADA's 2023 Kelly West Award for Outstanding Achievement in Epidemiology. She will deliver an award lecture on Saturday at 3:15 p.m. PT in Ballroom 6A-B. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
ADA Chief Executive Officer Charles Henderson and ADA President of Health Care and Education Janet Brown-Friday, RN, MSN, MPH, will address the 83rd Scientific Sessions during a special session Saturday at 9:45 a.m. PT in Halls GH. Watch a livestream or catch the recording on-demand on the virtual platform at ADA2023.org.
A. Enrique Caballero, MD, is the recipient of the 2023 Outstanding Educator in Diabetes Award. The award recognizes a distinguished health professional who has made outstanding educational efforts in the field of diabetes. Dr. Caballero will present the Outstanding Educator in Diabetes Award Lecture on Saturday at 10:45 a.m. PT in Halls GH. Watch a livestream or catch the recording on-demand on the virtual platform at ADA2023.org.
SURMOUNT 2 principal investigator W. Timothy Garvey, MD, discusses data presented Friday at the Scientific Sessions on tirzepatide use for obesity and type 2 diabetes. Watch an on-demand recording of that symposium, SURMOUNT 2 Trial Results and Potential Role of Tirzepatide in Treating Obesity in Type 2 Diabetes, on the virtual platform at ADA2023.org.
Presenter Martin A. Thelin, MD, PhD, shares insight into a symposium that begins Saturday at 8:00 a.m. PT in Room 30. Watch a livestream or catch the recording on-demand on the virtual platform at ADA2023.org.
Read More
In a symposium beginning Saturday at 8:00 a.m. PT in Room 28, David G. Armstrong, DPM, MD, PhD, and other panelists will present approaches providers can implement to help their patients living with diabetes get ahead of foot injuries and improve foot health. Watch a livestream or catch the recording on-demand on the virtual platform at ADA2023.org.
Read More
During a symposium beginning Saturday at 8:00 a.m. PT in Ballroom 20A-C, panelists including Ronnie Aronson, MD, will discuss CGM’s potential use as a preventative tool and its role for people living with diabetes who are treated with insulin compared to those who are not. Watch a livestream or catch the recording on-demand on the virtual platform at ADA2023.org.
Read More
In a symposium beginning Saturday at 8:00 a.m. PT in Ballroom 6A-B, experts including Christopher Gardner, PhD, will illustrate a multifaceted understanding of how humans use food and how nutrition can improve health in people with diabetes. Watch a livestream or catch the recording on-demand on the virtual platform at ADA2023.org.
Read MoreScientific Sessions Meeting Planning Committee Chair Alice Y.Y. Cheng, MD, FRCPC, previews noteworthy sessions on Saturday’s schedule.
Francis S. Collins, MD, PhD, who led the Human Genome Project, welcomed attendees to the 83rd Scientific Sessions with a message about the potential of omics data to drive new avenues of research into complex diseases like diabetes. Already, genome-wide association studies take information about common variations in the genome to identify statistically significant differences between people with a given disease and those without.
Read more
Pathway to Stop Diabetes® researchers, including Aleksandar D. Kostic, PhD, presented their new approaches for working toward a cure for this pervasive disease. These investigators are looking at the gut microbiome, cloaked beta-cells, branched-chain amino acid, dysregulation of the gut-brain axis by sugar, and diabetes distress with new perspectives with funding from the American Diabetes Association®. Read more
Therapeutic inertia is a common problem in managing type 2 diabetes. Experts including Kevin M. Pantalone, DO, ECNU, FACE, addressed how it can be prevented, such as achieving A1C targets within a year of treatment, leveraging the entire health care team in the patient’s journey, and having accessibility to the patient’s electronic health record. Read more
New to the Scientific Sessions lineup, the Innovation Challenge invites six contestants to pitch their concepts for improving the lives of people living with diabetes before a panel of potential funders. Three finalists will earn a private audience with the judges, explained ADA Chief Scientific and Medical Officer Robert Gabbay, MD, PhD. Read more
A panel including Ellen Leschek, MD, will discuss teplizumab clinical trial results and the role of the CD3-directed monoclonal antibody in delaying the progression from stage 2 type 1 diabetes to stage 3. Joining Dr. Lesheck will be researchers, clinicians, and a patient with type 1 diabetes. Read more
Michael J. Haller, MD, and Antionette Moran, MD, will present data and arguments in support of technology and immunomodulation, respectively, in treating patients with type 1 diabetes. Dr. Haller said most experts likely agree there will be a role for both going forward and each should be discussed and offered to patients. Read more
Genome-wide association studies and polygenic risk scores are important tools in the field of genetics and have shown to also impact diabetes research. Experts including Inês Barroso, PhD, will present information on how GWAS and PRS have helped in the prevention, early diagnosis, and management of type 2 diabetes. Read more
The Health Disparities Committee of the American Diabetes Association® has chosen the top 10 abstracts for presentation. These abstracts focus on health care disparities in diabetes outcomes, showcase research that explores the underlying factors in diabetes disparities, and demonstrate practical interventions that may contribute to eliminating those disparities. Read more